Name: 8th International Conference on Human Genetics and Genetic Disorders
Start: 2024-03-21
End: 2024-03-23
Location: France

What People Say…

“Dear Louise, I am so great full for your help and your interest I am so happy to have such experience where I can present my work and have an opportunity to share my knowledge with other scientists. This experience gives me a lot (acquiring a new data and knowing a new person). ”

Dr.Mariem Ennouri

“Participation in the Pulsus conference is like a breeze of fresh air in the field of human genetic research. It is inspiring to know about brilliant ideation of problems plaguing the humanity and learn about novel techniques innovated by the scientific community.”

Dr.Manish Shukla

Conference Information

Human Genetics 2024

The most anticipated event of 2024 is the "8th International Conference on Human Genetics and Genetic Disorders" which is scheduled to take place on March 21-22, 2024 in Paris, France. Human Genetics 2024 Conferences cordially invites all renowned researchers and scholars from around the globe to attend.

You will be able to experience the conference abilities through a variety of exciting events, including a global seminar and discussion of cutting-edge research in the disciplines of human genetics, gene therapy, cytogenetics, and more. It is an opportunity to build a network, listen, debate, share knowledge, and gather inspired genetics researchers and scientists.

Human Genetics 2024 Conferences is the ideal set of circumstances for extending the convergence of participants from all around the world. Let us combine, demonstrate, transfer, and collaborate with cutting-edge technology to investigate the subjects of human genetics and curative measures for genetic disorders, making the best impression with new drug innovations, developments, and receiving name recognition and certificates from our world-class prestigious committee members over the course of these three days. The conference's trademarks are famous speakers from throughout the world, recent approaches, progress and news in human genetics, and relevant discussions.

Our meeting will take place in Paris, which will provide an excellent setting for both social and scientific activities. We are delighted to have you in Paris.

We look forward to meeting you in Paris.

Regards,

Organizing Committee

Human Genetics 2024

Important Deadlines and Venue

Mark your calendar for the following important Human Genetics 2024 Conferences deadlines

Abstract Submission Deadline (Extended): October 25, 2024. (*)

Final Paper Submission Deadline: May 20, 2024 (*)

Final Phase Early Bird Registration Deadline: June 14, 2024. (*)

Notification of Abstract Acceptance/ Rejection: 1-2 days.

Conference Dates: March 21- 22, 2024.

*By Midnight-11:59 pm Paris Time Zone

Join as a group with a minimum of 4 or 5 members and get a 45% discount on the total registration fee.

Exciting early bird registration perks await you. (Valid till 2nd phase early bird registration)

Venue and Accommodation: Millennium Hotel Paris Charles De Gaulle 2 AllÃƒÂ©e du Verger Roissy en France, France 95700

Note: This is a tentative venue. Once we received the hotel confirmation, the confirmed venue will be updated soon.

Enjoy complimentary breakfast, free Wi-Fi, and the possibility of early check-in/check-out (depending on room availability). Rooms are available as single or double occupancy.

It would be greatly appreciated if you could send us a mailto genetics@pulsusevents.net regarding any separate or additional accommodation bookings that you may need. Please include the details of your preferred package or desired number of nights, so that we can efficiently assist you with your arrangements with the personalized registration link.

Please be advised that in order to receive the confirmation receipt of your room reservation for the dates of your choice, prompt payment of the applicable fee is required.

To know more, visit: Human Genetics 2024 Venue

Contact genetics@pulsusevents.net for accommodation-related queries.

Market Analysis

The "World Genetics Market" research study, which spans the years 2017 to 2026, provides an overview of the most recent trends and advancements in the global market. Also, it addresses all crucial growth aspects. It offers a thorough review of the business expansion strategies, market situation, growth markets, and outlook for the leading manufacturers. The report's objective is to present regional development for the market's projected growth rate as well as market-driving elements like sales revenue. It includes in-depth study and analysis of important factors and emphasises the state of the market using a number of research techniques, including SWOT and PESTLE analysis. The research also offers valuable information on emerging strategies and prospects for global players.

Insights and Market Analysis on Global Genetic Market:

"Genetic engineering" refers to the process of changing an organism's or species' genes with the goal of enhancing its capabilities. Organizations involved in clinical research, biotechnology, and pharmaceutical employ the technology. The most popular treatment for cancer and other infectious disorders in medicine is gene therapy.

At a CAGR of 10.0% between 2017 and 2026, it is anticipated that the global market for genetic engineering would be worth USD 5998.3 million by 2028, up from USD 3053.5 million in 2021.The widespread use of technologies like CRISPR/Cas9, TALEN, and ZNF in gene therapy for various genetic illnesses and life-threatening conditions is most likely what will drive this market's growth.

With an analysis that conforms with industry standards and high data quality, the study does a great job of highlighting the main opportunities that are present in the global genetic engineering market in order to help players build a strong position in the market. Access to reliable market projections, including those for the size of the worldwide genetic engineering industry's overall revenue, is made available by the report.

In general, the research serves as a beneficial resource for participants aiming to edge out rivals and assure long-term success in the worldwide genetic engineering market. With the aid of reliable sources, all of the discoveries, information, and data presented in the study have been confirmed and revalidated. Analysts examined the global market for genetic engineering in-depth using a brand-new, cutting-edge approach to research and analysis. The scope and size of the market are indicative of the participants, region (country), type, and application divisions of the worldwide genetic engineering market. Players, stakeholders, and other participants in the worldwide genetic engineering market will be able to get an advantage by using the study as a valuable resource. The segmental study' main focus is on the revenue and projections for the years 2017 through 2026, broken down by kind and application.

Study of the Competitive Environment and Market Share for Genetics

The genetic market's competitive environment offers information and specifics about companies. This research carefully examines and precisely analyses the player's revenue from 2017 through 2026. Additionally, it offers in-depth research supported by trustworthy data on participants' revenue (at the global and regional levels) for the years 2017 through 2026. Included information includes a description of the company, its principal businesses, overall revenue and sales, revenue from the genetic engineering sector, the date the market for genetic engineering products was introduced, recent advancements, and other information.

Segmentation the Global Genetics Market by Types, Applications, and Regions

We investigate the global market for genetics and give data on the market's size by region (countries). Depending on the application, the genetic engineering market is segmented into the United States, Europe, China, Japan, Southeast Asia, India, and the Rest of the World. The research includes market sizes by region for the period of 2017 to 2026. Also, it gives market size predictions for sales and revenues from 2017 to 2026 by participant, product type, and application area.

According to a worldwide genetic market zone study, the United States of America is the world's biggest market for the rapidly expanding field of human genetics. Over the projection period, the US market for human genetics is anticipated to expand at a CAGR of 9.9%, reaching USD 19.99 billion in 2023.

Europe: The market in Europe was assessed to be worth $1.22 billion in 2017, and by 2021, it is anticipated to be worth $1.81 billion, growing at a CAGR of 8.2%.

Pacific Asia: The market is anticipated to grow to USD 5.30 billion in value by 2021 from USD 3.39 billion in 2017, a 9.3% CAGR. China is expected to see primary growth of 13.2% throughout the predicted period.

Near East: In 2017, it was projected that the global market for human genetics was worth $419.4 million, and that it would grow at a 13.9% CAGR over the following five years.

Segmentation

The target markets for the growth of the global human genetics market include research and development firms, genetics and genomics firms, medical research facilities, academic medical centers, and universities. The international market for human genetics is composed of the instruments, methodologies, applications, and end-user segments.

The global market for human genetics is expected to expand steadily between 2017 and 2026, with a CAGR of 11.5 percent. The global genetic market is expected to increase from $774.99 million in 2017 to $25948.46 million in 2026, rising at a CAGR of 14.37 percent during the forecast period.

The list of the major players in the genetic engineering market are listed below: Fisher Scientific Amgen, Genentech, Merck Group Horizon Discovery, Therapeutics Sangamo, and Biopharmaceuticals Transposagen.

Scientific Sessions

Session 1: Molecular Biology

The field of molecular biology examines the molecular underpinnings of biological activity between the numerous systems of a cell, including interactions between distinct DNA, RNA, and protein types as well as the production of these proteins, and how these interactions are controlled. It has a wide range of uses, including gene discovery, understanding disease molecular mechanisms, and developing new treatment methods based on gene cloning, expression, and regulation. Gene expression, epigenetics, chromatin structure and function, RNA processing, non-coding RNA roles, and transcription are among the research areas. Molecular biology, DNA replication, repair, and recombination, transcription, RNA processing, post-translational modification, proteomics, mutation, site-directed mutagenesis, epigenetics, chromatin structure and function, and molecular mechanisms of disease are currently the concepts of the most advanced research.

Molecular Cloning
Immunology
Biomolecules
Developmental biology

Related Conferences:

Related Associations:

French Association of Genetic Counsellors (AFCG) | Genetic Association in Bosnia and Herzegovina (GENUBIH) | Hellenic Association of Medical Geneticists | Latvian Association of Human Genetics | Lithuanian Association of Genetics | Slovenian Association of Medical Genetics | Spanish Association of Human Genetics | Swiss Association of Genetic Counsellors | All-Ukranian Genetics Association Experts of Medical and Laboratory Genetics

Associated Journals:

Associated Societies:

Session 2: Healthcare

Healthcare markets are characterized from an economic perspective by a few key elements. Because of some of these economic factors, there is extensive government involvement in healthcare markets and operations. Prices have very little impact on consumer demand for healthcare services. There are inherent risks for both consumers and producers in terms of requirements, results, and service costs. Principal-agent issues are common, and information on patients, providers, and other industry participants is highly asymmetric. With activities ranging from research to production to facility management, the healthcare sector covers a wide range of sectors.

Medicine and Health
Careers in Health Care
Health Care Technologies
Healthcare services

Related Conferences:

Related Associations:

Spanish Association of Human Genetics | French Association of Genetic Counsellors (AFCG) | Lithuanian Association of Genetics | Swiss Association of Genetic Counsellors | All-Ukranian Genetics Association Experts of Medical and Laboratory Genetics | Genetic Association in Bosnia and Herzegovina (GENUBIH) | Hellenic Association of Medical Geneticists | Latvian Association of Human Genetics

Associated Journals:

Associated Societies:

Session 3: Human Genetics

It is the study of how characteristics are transmitted on from parents to their offspring. Human inheritance is identical to that of other organisms in all important ways. A key area of research in genetics is the study of human heredity. This fascination is largely motivated by a fundamental curiosity about what makes people tick and what makes them the way they are. Practically speaking, the prediction, diagnosis, and treatment of diseases with a genetic component depend heavily on our ability to understand human heredity. Medical genetics is a field that was created in an effort to understand the genetic foundation of human health. In general, human genetics now has a focus and purpose owing to medicine.

Familial Alzheimer's Disease.
Familial FTD.
Familial Prion Disease.
Genetic Counseling.

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 4: Gene Therapy

Gene therapy is a medical method used to treat or prevent disease by addressing the underlying genetic problem. Gene therapy treatments enable medical professionals to treat a condition by altering a person's genetic makeup rather than using medications or surgery. The three primary subtypes of gene therapy are ex vivo, in vivo, and in situ. Ex vivo gene therapy entails removing the patient's harmed cells and genetically altering them. Another name for this type of therapy, which is especially beneficial for blood diseases, is in vitro gene therapy. One final gene therapy strategy involves administering the viral vector directly to the patient.

Somatic cell type
Germ line cell type
Gene expression

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 5: Medical Genetics

Medical genetics research is predicated on the theory that humans become "fat" through evolution. In this study, human fat is gathered, compared to the fat of different nonhuman primates, and evaluated for good or poor fat. Genetic medicine expands in areas like gene therapy, individualized medicine, and predictive medicine, much as medical genetics focuses on the diagnosis and treatment of hereditary illnesses.

Immunogenetics
Pharmacogenetics
Biochemistry
Precision Medicine
Biostatistics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 6: Clinical Genetics

Clinical genetics is a field of medicine that provides genetic counselling and diagnostic services to individuals or families dealing with or at risk for genetically based disorders. Every body system can be impacted by genetic diseases, regardless of age. The purpose of genetic services is to support people in living and procreating as normally as possible who have genetic abnormalities or are at risk for developing them.

Diagnostic testing
Presymptomatic and predictive testing
Carrier testing
Pharmacogenetics.
Prenatal testing

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 7: Neurogenetics

Neurogenetics is a branch of study that combines genetics and nervous system science to investigate the function and capacity of the sensory system as well as the alleged peculiarities in its function. The phrase "genotype" refers to a creature's hereditary look, whereas the term "aggregate" refers to a living entity's actual qualities or properties. The term "genotype" refers to the genetic composition that defines the many traits communicated by individual organic entities, whereas "aggregate" refers to differences in brain properties between individuals of comparable species in respect to the sensory system. Many of the neurogenetic disorders, such as Alzheimer's, Huntington's, and epilepsy, are still major study subjects today, and much is currently known about the hereditary basis of these and many other conditions..

Clinical exome sequencing
Transgenic RNAi

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 8: Gene Mutation

A mutation is a modification to the nucleotide sequence of the genome of an organism, pathogen, or extrachromosomal DNA. Experts have identified the most frequent immunodeficiency diseases caused by genetic mutation. The researchers investigated the infants' inflammatory bowel disease. The disorder was caused by a mutation that prevented natural killer cells from properly developing, resulting in a reduction in the amount of immune cells.

Harmful mutation.
Beneficial mutation.
Prion mutation
Somatic mutation
Amorphic mutation

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 9: Cytogenetics

The study of chromosomal structure, gene placement on chromosomes, and chromosomal behavior during cell division is known as cytogenetics. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids, as well as in vitro and in vivo assessment of DNA interaction, genotoxicity, and oxidative stress induced by iron oxide nanoparticles, because iron particles have been shown to induce cytotoxicity in various cancer cell lines via reactive oxygen species generation.

Mitosis
Meiosis
Fluorescent in situ hybridization
Comparative genomic hybridization

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 10: Genetic Epidemiology

The field of genetic epidemiology is defined by a convergence of approaches developed from traditional disease transmission research, population and family-based disease transmission studies, measurements, and, most importantly, bioinformatics. The research of quality and condition, as well as the examination of quality and condition collaboration, use explicit parts of these controls. Both quantitative and subjective features have the potential to be intriguing. Disease transmission research incorporates novel case-control, family, and population-based techniques, as well as genotyping from several sources.

Molecular Epidemiology
Statistical Genetics
Behaviour genetics
Bioinformatics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 11: Chromosome abnormalities

Current reviews have mainly focused on cancer in the sense that renal carcinoma occurs as a result of chromosomal abnormalities, with chromosome translocation occurring frequently, in which a piece of one chromosome can be found attached to another. There are two types of chromosomal abnormalities: numerical abnormalities and structural abnormalities. A chromosome or chromosomes that have been changed are responsible for the numerical anomaly. A structural anomaly is an alteration in the structure of the chromosome. Numerical disorders

Structural disorders
Replication of DNA

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 12: Population Genetics

The current study is attempting to identify genetic relationships between European, Mediterranean, and South-West Asian populations, which is a branch of evolutionary biology and a subdivision of genetics concerned with genetic variations between populations. In population genetics, a large number of populations have been studied and are being applied to new population samples. The existing population sample reference library allows for global inference of novel sample associations.

Describing the pitch of genetic variation
Perceiving selection
Demographic interference
Evolution of genetic systems

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 13: Genomics

Genomics is the research on the structure, function, mutation, sequencing, and editing of genomes. New discoveries in genomics, such as nanopore technology for sequencing human genomes, have accelerated progress. Nanopore technology has been widely exploited to sequence the genomes of bacteria and viruses. Micro pore human genome sequencing identifies structural changes in patient samples with high precision. Proteomics

Bioinformatics
Pharmacogenomics
Metagenomics
Computational biology
Nutrigenetics science

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 14: Genetic Disorders

Genes are the foundation of inheritance. They are passed down through the generations. They have DNA in them, which contains the instructions for building proteins. In cells, protein molecules would be doing the majority of the work. They transport molecules, build structures, destroy toxins, and perform a variety of other maintenance tasks. Single-gene disorders are one of three types of genetic disorders in which a mutation affects only one gene. One example is sickle cell anaemia. When chromosomes (or sections of chromosomes) are missing or changed, chromosomal diseases occur. Chromosomes are the structures that house our genes. Down syndrome is a chromosomal disorder. Complex disorders occur when there are mutations in two or more genes.

Heart disease
Hypertension
Infertility
Diabetes
Obesity
Cancer

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 15: Genetic Counselling

A genetic counsellor proposes assisting couples, families, and individuals in understanding their inherited genetic condition in order to make health decisions. A new genetic abnormality causing intellectual impairment has been identified. The genetic mutation that causes X-linked syndrome intellectual disability is inherited and passed on to offspring by unaffected females; however, symptoms such as behavioral difficulties, small average brains, and testes have been observed in males.

Cardiovascular genetics
Hereditary cancer genetics
Neuro genetics
Pediatric genetics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 16: Ethical and Social Implications of Gene Editing

In the recent decade, many ethical, legal, and social concerns (ELSI) about genetic testing and research have been raised. These concerns should be raised with patients so that they are aware of the risks and benefits of genetic testing and may use it safely and correctly. This chapter provides a quick summary of some of the most critical ELSI questions surrounding genetic testing. Concerns have been raised about the use and possible commercialization of genome sequencing. Concerns range from a genetic test's analytical and clinical validity to the perceived stigma of having a genetic difference to the obligation to disclose genetic information to potentially impacted individuals.

Communicating test results
Direct-to-consumer tests
Duty to disclose
Genetic discrimination
Psychosocial impact
Reproductive issues

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 17: Gene Mapping

Gene mapping determines the location of the gene as well as the distance between genes. The development of genetic markers and a mapping population can be utilized to construct a genetic map. The most recent work focuses on reconstructing recent population history while mapping rare mutations using haplotypes. The haplotype-based method is used to characterize rare variants and map disease-linked alleles. Using inflammatory bowel disease mapping, two unusual IBD haplotypes associated with asthma patients were recently discovered. Molecular marker

Genome sequencing
Electrophoresis
Restriction enzymes

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 18: Genetic analysis of DNA structure

DNA is a double fold helix structure made up of two chains of particles that communicate hereditary guidance for the course of events and the development of organic entities. In any case, researchers have just discovered another DNA structure inside the human cell known as the "I-motif." It looks like a bunch of DNA. Analysts are working to recognize the new DNA's capability. They suppose it would be utilized for perusing DNA groupings.

Genetic engineering
DNA profiling
DNA enzymes
DNA nanotechnology

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 19: Pharmacogenetics

Pharmacogenetics is the study of acquired inherited differences in pharmaceutical metabolic pathways that might influence specific drug responses, both positive and negative. Metabolic pathways have the ability to influence individual drug reactions, both positively and negatively. Pharmacogenetics is frequently used interchangeably with pharmacogenomics, which investigates the piece of acquired and gained inherited complexities in association with cure response and drug direct through a productive examination of characteristics, quality things, and between and intra-particular variation in quality verbalization and limit. In oncology, pharmacogenetics is the study of germline changes (for example, single-nucleotide polymorphisms affecting characteristics coding for liver impetuses responsible for drug declaration and pharmacokinetics), whereas pharmacogenomics refers to physical changes in tumoral DNA that cause changes in sedating response.

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 20: Immunogenetics

The area of therapeutic study known as immunogenetics, sometimes known as immunogenetics, looks at the relationship between the genetic makeup of an individual and their susceptibility to disease. Diseases of the susceptible system, including type 1 diabetes, are quirky genetic features brought on by failures in the defense mechanism. A new target characteristic for accommodating strategies may be perceived upon recognizing evidence of attributes identifying the safe defects. Nevertheless, hereditary variations can also be used to characterize the disease-causing immunological pathway. According to Work, the phrase "immunogenetics" is based on the terms "immunology" and "genetic traits," and it is described as "a sub-class of innate traits emphasizing on the inherited explanation of the protected reaction." The science of inherited traits investigates the passing of qualities from one generation to the next.

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Session 21: Stem Cell Research

Stem cells are undifferentiated natural cells found in multicellular organisms that go through mitosis to make more cells. Stem cells are divided into two types: embryonic stem cells and adult stem cells. The stem cell treatment was discovered to be a life-saving treatment for those suffering from aggressive malignancies and blood problems. The umbilical cord of a newborn can be harvested for stem cells. They can also be obtained from blood and bone marrow. The method of using stem cells to treat and prevent disease or confusion is known as stem cell treatment. Although bone marrow transplantation is the most prevalent stem cell therapy, there are additional stem cell treatments that use umbilical cord blood.

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

About Conference

After a successful completion with thoughtful insight and a positive response from Human Genetics 2023 participants. Our organizing group is looking forward to our forthcoming event "8th International Conference on Human Genetics and Genetic Disorders" in Paris, France from March 21-22, 2024.

The major goal of Human Genetics 2024 Conference is to invite our distinguished guests to the next conference to share and exchange their knowledge. It is a worldwide forum for business delegations, business-to-business meetings, poster presentations, workshops, symposia, networking, and other activities. It will provide a platform for you to gain massive exposure and networking by presenting your products and services. Take advantage of the opportunity and offer your unique ideas, new technology, and recent research findings.

This programme will be an ideal platform for interacting with keynote speakers, plenary speakers, and other participants. Furthermore, as poster and oral presentations, this programme will provide an opportunity to discuss research, novel methodologies, or clinical experiences. We make certain that all participants, including speakers and delegates, leave with new ideas and skills.

Why to attend?

To show their most recent research works.
To make more contacts with the other specialist and investigates to continue with the assessment work.
To get data on the connected fields.
An global gathering gives a typical stage to divide information between academicians and scientists from different nations.
It also offers opportunities to the connected associations to share information about their latest things and besides gives a phase to notice of their associations, from this time forward growing their acclaim.
All-hands conferences and Poster introductions by worldwide specialists
Targets creating public mindfulness by talking about different progressions and difficulties in Human Genetics and Genetic Disorders

Target audience

Scientists
Professors
Research Scholars and students
Manufacturing Medical device Companies Companies
Genealogy Associations
Clinical genomics
Research Professors
Diagnosis and Treatment
Junior/Senior research fellows of Genetics
Genetic counseling
Gene therapy
Genomics
Pharmacologists
Genetic epidemiologists
Geneticists
NGO’s and Health Clubs

Visa Process

Is there a VISA problem?

We provide VISA support documents to each participant to assist them with their VISA application procedure. The following are the documents:

The official Invitation Letter
The official acceptance letter for the abstract
The Visa covering letter has been received

Points to keep in mind:

Only when you've successfully registered for your conference, will you receive a Visa Support Letter (the formal letter of invitation).
Only the individual who has been accepted to attend the conference can receive a Visa Support Letter.
Visa Support Letters will only be sent as PDF attachments through email.

Please contact the Conference Manager if you have any questions.

To get a Visa Support Letter, contact Ms. Larissa Mathew at genetics@pulsusevents.net

The issue with VISA??

To support the participants in his/her VISA application process, we issue each participant with VISA supporting documents. The documents are as follows:

· The official letter of Invitation

· The official letter of the Abstract Acceptance

· The receipt of the payment

· Visa Covering Letter

Points to be noted:

· Visa Support Letter (the official letter of invitation) will be issued only after you have successfully registered and paid for your conference

· Visa Support Letters can be issued only for the person accepted to attend the conference.

· Visa Support Letters will be issued only via email in PDF format

Please contact the Program Manager:

Ms. Sterla Anne via genetics@pulsusevents.net to arrange for a Visa Support Letter.

Kindly provide us with the following details to provide you with VISA SUPPORT LETTERS:

· Your name as mentioned on your passport

· A scanned copy of your Passport

· And Abstract Acceptance letter for Presenters

One can make the payment through the following Payment Methods:

· Payment Gateway/Stripe

· Pay Pal

· Bank to Bank transfer

Having trouble with Registration?

Please contact Ms. Sterla Anne via genetics@pulsusevents.net The team of Human genetice 2024 will provide you the INVOICE for the requested price with which he/she can make the Bank-to-Bank transfer.

Exhibiting Opportunities

We are thrilled to have you join us and share your innovative products and services in our Global Conference on Human Genetics and Genetic Disorders.

Our event offers exciting exhibiting opportunities to showcase your brand, connect with potential customers, and gain exposure in your industry.

The exhibit hall will serve as a central hub for attendees to offer the healthcare professionals a valuable platform to present new research, innovative products and services, and share best practices with peers. and to explore the latest products, technologies, and services that support high-quality.

Why exhibit?

Human Genetics 2024 provides a powerful platform for companies to showcase their brand, products, and services to a targeted audience. It's an excellent opportunity to connect with potential customers, generate new leads, and gain exposure in your industry. events are known for attracting high-quality attendees, including decision-makers, industry experts, and thought leaders, providing exhibitors with unparalleled networking opportunities

Don't let this opportunity pass you by. Now is the time to Book!

Your Exhibit Benefits

By exhibiting at the Human Genetics 2024 Conference you are entitled to the following:

Connect with more than 300+ attendees from more than 15+ Genetics researches specialties searching for innovative solutions to improve patient care.
Provides an opportunity for companies to increase their visibility and reach a wider audience. This can lead to increased brand awareness, which can help to attract new customers and clients.
This can lead to direct sales opportunities, as attendees may be interested in purchasing products or services on the spot. This can help to generate revenue and drive business growth.
By showcasing innovative products and services and sharing insights and expertise, companies can build credibility and gain the respect of industry peers.

Exhibit Booth Size

As an exhibitor, you will be a part of a select group of companies that will distinguish you from the competition.

3” x 3” sign with exhibitor name and booth number.
50% discount on both Extra delegate registrations and booth.
Engage current and prospective customers face-to-face

To Advertise

There are many advertising opportunities available for Human Genetics 2024,including print materials, digital promotions, and email advertising. You can place an advertisement in the Conference Program Book, which contains information on all sessions, meetings, special events, and exhibitor listings. In addition, there are opportunities for website banner ads, social media promotions and mobile app ads and notifications. These options provide a variety of ways for you to reach your target audience and increase visibility for your brand or organization.

Waiting List

The exhibition space fills up quickly. If the exhibition space is full, we will wait for cancellations of companies that wish to exhibit on a first-come, first-served basis.

Exhibiting Schedule

Exhibition set up: Friday 01 March 2024

Exhibition Dismantling: Monday 04 March 2024 after the Closing Ceremony

Deadline

Exhibitors, kindly submit your proposals on or before December 22th, 2024, to ensure its inclusion in the event. No content will be accepted after the deadline. Contact us for any concerns.

Please do not hesitate to contact us if you have any questions or concerns. We are here to assist you and ensure that your experience with us is a positive one.

We look forward to hearing from you.

For contact:
Sterla Anne Program Director | Human Genetics 2024
Ph/WhatsApp: +44 7537171400
Emai: genetics@pulsusevents.net